Important: The U.S. Food and Drug Administration strongly advises against using CBD, THC, or marijuana in any form during pregnancy or while breastfeeding. This article is for educational purposes only and is not medical advice. Discuss any questions with your obstetrician, midwife, or pediatrician.
The short answer to “is CBD safe for pregnant women” is: No, the FDA advises against it, and the precautionary stance is appropriate given what is and is not known. This page explains why, what the research actually shows, and what evidence-based options exist for the symptoms that often drive the question.
The bottom line
- The FDA strongly advises against CBD use during pregnancy and breastfeeding.
- Cannabinoids cross the placenta. They reach the developing baby.
- THC and likely CBD pass into breast milk and are detectable for days to weeks after use.
- Observational data raises concerns about fetal development, birth weight, and neurodevelopmental outcomes.
- The standard recommendation is to discontinue any CBD product if pregnancy is confirmed. Discuss with your obstetrician.
Why this is one of the clearest “no” answers in CBD content
Most CBD-related questions have nuanced answers — preliminary research, hedged language, “talk to your doctor.” Pregnancy is different. Several factors converge:
- The FDA’s stance is unambiguous, not equivocal
- Cannabinoids cross the placenta — not a hypothesis, an established pharmacology fact
- Observational human data raises concerns
- Definitive randomized trials cannot ethically be conducted
- Quality control of consumer CBD products has been inconsistent in independent testing
In short: the precautionary principle is appropriate, and the FDA has applied it.
What is known about cannabinoid exposure during pregnancy
A summary that does not overstate or understate:
- Placental transfer: Established for both THC and CBD.
- Breast milk: THC and its metabolites have been documented in human breast milk for days to weeks after use, even after single exposures in some studies. CBD likely passes similarly, though the data are more limited.
- Birth-weight associations: Maternal cannabis use during pregnancy has been associated with lower birth weight and other outcomes in observational studies. Confounding by tobacco and other substances limits some analyses, but the overall signal is not reassuring.
- Animal-model studies of cannabinoid exposure during fetal development have shown effects on developing nervous-system structures.
What is NOT available is randomized controlled trial data in pregnant humans. This is not a research gap that can be ethically filled, and the absence of such data does not mean exposure is safe. It means safety cannot be characterized with the precision pregnancy decisions warrant — which is itself a reason for caution.
What about pregnancy-related symptoms?
The driving question is usually a symptom: morning sickness, anxiety, sleep, pain. There are evidence-based options for each.
Nausea and vomiting of pregnancy
- First-line: Pyridoxine (vitamin B6), with doxylamine added if needed. The combination is FDA-approved as Diclegis.
- Second-line: Other antiemetics (ondansetron, metoclopramide) when needed.
- Severe cases (hyperemesis gravidarum): Specialist care, IV fluids, sometimes hospitalization.
Sleep difficulty in pregnancy
- Sleep position adjustments (left-side, supportive pillows)
- Treatment of contributing causes — restless legs syndrome is common in pregnancy and often related to low ferritin
- Sleep hygiene
- Discuss persistent insomnia with your obstetrician
Anxiety and mood in pregnancy
- Cognitive-behavioral therapy
- Selected medications when appropriate, weighed against risks; some SSRIs are commonly used in pregnancy after individual risk-benefit conversation
- Prenatal counseling and support
Pain in pregnancy
- Acetaminophen is the most-commonly-used analgesic in pregnancy with established history of use
- NSAIDs are generally avoided after 20 weeks
- Physical therapy, support belts for back pain, positioning strategies
- Discuss any persistent pain with your obstetrician
These are all well-trodden clinical paths with much more evidence behind them than CBD use in pregnancy.
Topical CBD products
Topical CBD has minimal systemic absorption, but pregnancy is a time to minimize exposures whose effects have not been well studied. The precautionary principle applies. Discuss any topical use with your obstetrician.
What we offer at New Phase Blends
We make third-party-tested CBD products designed for general wellness use in non-pregnant adults. They are not formulated, tested, or marketed for use during pregnancy or breastfeeding. We strongly support the FDA’s recommendation against CBD use during pregnancy and lactation.
Frequently asked questions
Is CBD safe for pregnant women? No. The FDA strongly advises against CBD use during pregnancy and breastfeeding.
I used CBD early in pregnancy before I knew. Should I be worried? Common situation. Tell your obstetrician or midwife so they can review your history. Isolated exposures before pregnancy recognition typically do not change pregnancy management, but the conversation is worth having.
Is hemp-seed oil safe in pregnancy? Refined hemp-seed oil contains negligible cannabinoids and is sold as a food and skincare ingredient. This is different from CBD-containing products. Discuss specific products with your obstetrician.
What about CBD for postpartum anxiety? Postpartum anxiety and depression are real and treatable. The first conversation should be with the obstetrician, midwife, or mental-health clinician — not a CBD product. Effective treatments exist.
Disclaimer: The statements made on this page have not been evaluated by the Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease and are not intended for use during pregnancy or breastfeeding. The information here is for educational purposes only and is not a substitute for advice from a licensed medical professional. The FDA strongly advises against CBD use during pregnancy and breastfeeding.
